Lv4
410 积分 2024-06-15 加入
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
4天前
已完结
A phase 1, open-label, multicenter, non-randomized study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of AZD4573, a potent and selective CDK9 inhibitor, in subjects with relapsed or refractory hematological malignancies
5天前
已关闭
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
1个月前
已完结
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia
1个月前
已完结
Update on feline soft tissue sarcomas
2个月前
已完结
Surface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL
3个月前
已完结
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes
4个月前
已关闭
Neuroimmunometabolic co-evolution in the tumor micro- and macroenvironment
4个月前
已完结
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes
5个月前
已关闭
A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias
5个月前
已关闭
皖公网安备34019202002308
